These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 20840872

  • 1. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
    Li XH, Peng J, Tan N, Wu WH, Li TT, Shi RZ, Li YJ.
    Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
    [Abstract] [Full Text] [Related]

  • 2. Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.
    Pei Y, Ma P, Wang X, Zhang W, Zhang X, Zheng P, Yan L, Xu Q, Dai G.
    Eur J Pharmacol; 2011 Sep; 666(1-3):165-72. PubMed ID: 21641341
    [Abstract] [Full Text] [Related]

  • 3. Asymmetric dimethyl arginine induces pulmonary vascular dysfunction via activation of signal transducer and activator of transcription 3 and stabilization of hypoxia-inducible factor 1-alpha.
    Pekarova M, Koudelka A, Kolarova H, Ambrozova G, Klinke A, Cerna A, Kadlec J, Trundova M, Sindlerova Svihalkova L, Kuchta R, Kuchtova Z, Lojek A, Kubala L.
    Vascul Pharmacol; 2015 Oct; 73():138-48. PubMed ID: 26091577
    [Abstract] [Full Text] [Related]

  • 4. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats.
    Sasaki A, Doi S, Mizutani S, Azuma H.
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1480-7. PubMed ID: 17322279
    [Abstract] [Full Text] [Related]

  • 5. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X, Yang Y, Yang D, Tong G, Lv S, Lin X, Chen C, Dong W.
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [Abstract] [Full Text] [Related]

  • 6. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
    Pak O, Sommer N, Hoeres T, Bakr A, Waisbrod S, Sydykov A, Haag D, Esfandiary A, Kojonazarov B, Veit F, Fuchs B, Weisel FC, Hecker M, Schermuly RT, Grimminger F, Ghofrani HA, Seeger W, Weissmann N.
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
    Dai YP, Bongalon S, Tian H, Parks SD, Mutafova-Yambolieva VN, Yamboliev IA.
    Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
    [Abstract] [Full Text] [Related]

  • 8. Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells.
    Shan X, Gegentuya, Wang J, Feng H, Zhang Z, Zheng Q, Zhang Q, Yang K, Wang J, Xu L.
    Am J Physiol Cell Physiol; 2023 Oct 01; 325(4):C1058-C1072. PubMed ID: 37661916
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G, Wang X, Li Y, He L.
    Stem Cell Res Ther; 2017 Feb 10; 8(1):34. PubMed ID: 28187784
    [Abstract] [Full Text] [Related]

  • 11. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S, Peng F, Li ML, Duan WB, Peng CQ, Wu SJ.
    Am J Physiol Heart Circ Physiol; 2020 Aug 01; 319(2):H377-H391. PubMed ID: 32559140
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
    Paffett ML, Lucas SN, Campen MJ.
    Vascul Pharmacol; 2012 Aug 01; 56(1-2):64-73. PubMed ID: 22146233
    [Abstract] [Full Text] [Related]

  • 13. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
    Pullamsetti S, Kiss L, Ghofrani HA, Voswinckel R, Haredza P, Klepetko W, Aigner C, Fink L, Muyal JP, Weissmann N, Grimminger F, Seeger W, Schermuly RT.
    FASEB J; 2005 Jul 01; 19(9):1175-7. PubMed ID: 15827267
    [Abstract] [Full Text] [Related]

  • 14. cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.
    Pullamsetti SS, Savai R, Schaefer MB, Wilhelm J, Ghofrani HA, Weissmann N, Schudt C, Fleming I, Mayer K, Leiper J, Seeger W, Grimminger F, Schermuly RT.
    Circulation; 2011 Mar 22; 123(11):1194-204. PubMed ID: 21382892
    [Abstract] [Full Text] [Related]

  • 15. Oxymatrine prevents the development of monocrotaline-induced pulmonary hypertension via regulation of the NG, NG-dimethyl-L-arginine metabolism pathways in rats.
    Dai G, Li B, Xu Y, Zeng Z, Yang H.
    Eur J Pharmacol; 2019 Jan 05; 842():338-344. PubMed ID: 30419238
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Cheng Y, Yu M, Xu J, He M, Wang H, Kong H, Xie W.
    BMC Pulm Med; 2018 Aug 07; 18(1):130. PubMed ID: 30086741
    [Abstract] [Full Text] [Related]

  • 17. Protective effects of 18β-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway.
    Zhang M, Chang Z, Zhang P, Jing Z, Yan L, Feng J, Hu Z, Xu Q, Zhou W, Ma P, Hao Y, Zhou R.
    Chem Biol Interact; 2019 Sep 25; 311():108749. PubMed ID: 31325423
    [Abstract] [Full Text] [Related]

  • 18. Rho/ROCK signal cascade mediates asymmetric dimethylarginine-induced vascular smooth muscle cells migration and phenotype change.
    Zhou YM, Lan X, Guo HB, Zhang Y, Ma L, Cao JB.
    Biomed Res Int; 2014 Sep 25; 2014():683707. PubMed ID: 25121106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q, Peng J, Liu SY, Wang CJ, Xiang DX, Xiong XM, Hu CP, Li YJ.
    Clin Exp Pharmacol Physiol; 2010 May 25; 37(5-6):630-5. PubMed ID: 20132235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.